Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and...

TUESDAY, Sept. 17, 2024 -- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1...

learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes

learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes

WASHINGTON, USA – New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain...

WASHINGTON, USA – New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...

MONDAY, Sept. 16, 2024 -- Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that...

TUESDAY, Sept. 10, 2024 -- Higher consumption of oats, gluten-containing cereals, and fruits by young children is associated with an increased risk...